Remifemin
Remifemin, a brand of Schaper & Brümmer GmbH & Co. KG (Salzgitter, Germany), manufactures and distributes hormone-free herbal pharmaceuticals — built on a proprietary Black Cohosh extract — for women experiencing menopausal symptoms, sold exclusively through pharmacies across 35+ countries.
- Company typePrivate
- Founded-
- HeadquartersSalzgitter, Germany
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What Remifemin does
Remifemin is a German herbal pharmaceutical product brand specializing in hormone-free treatments for menopausal symptoms, owned and manufactured by Schaper & Brümmer GmbH & Co. KG, headquartered in Salzgitter, Germany. The product family comprises Remifemin plus Johanniskraut, Remifemin, Remifemin mono (oral film-coated tablets in various pack sizes), and Remifemin FeuchtCreme (a hormone-free medical device cream for vaginal dryness), all built around the proprietary iCR-Special Extract — an isopropanolic extract from Cimicifuga racemosa (Black Cohosh) root stock that contains no hormones or phyto-hormones. The extract has been evaluated in over 30 clinical studies involving more than 13,000 patients between 1987 and 2016, establishing a substantial clinical evidence base for efficacy in treating hot flashes, night sweats, sleep disturbances, and mood symptoms.
The business operates a pharmacy-exclusive go-to-market model, distributing products through both physical pharmacies and online pharmacy platforms (Amazon, DocMorris, ShopApotheke, Medikamente-per-Klick, ApoDiscounter, among others) across 35+ countries spanning Europe, Asia, North America, the Middle East, and Oceania. Retail unit prices range from approximately €10.98 to €61.79 per pack depending on SKU and channel. Revenue is generated entirely through one-time OTC transactions with inherent repeat-purchase dynamics tied to chronic-condition usage. Marketing combines a content-rich website, the Wechselweiber Blog, a newsletter, an Instagram presence (@4healthywomen), and the newly launched Remifemin Wechseljahre App for iOS and Android — which provides symptom tracking, dosage reminders, and expert content to deepen direct consumer engagement.
The company is privately held with no disclosed funding rounds, no M&A activity, and no public revenue figures; it appears to be an established, independent mid-sized German pharmaceutical manufacturer focused on a single therapeutic category (women's menopause health) with a single core active ingredient. Operational scale indicators include 35+ country distribution and 30+ clinical studies, but specific headcount, revenue, and ownership structure remain undisclosed in available sources.
Remifemin firmographics
Firmographics- Name
- Remifemin
- Legal name
- Schaper & Brümmer GmbH & Co. KG
- Website
- https://remifemin.de
- Company type
- Private
- Operating status
- Operating
- Short description
- Remifemin, a brand of Schaper & Brümmer GmbH & Co. KG (Salzgitter, Germany), manufactures and distributes hormone-free herbal pharmaceuticals — built on a proprietary Black Cohosh extract — for women experiencing menopausal symptoms, sold exclusively through pharmacies across 35+ countries.
- Ownership category
- akta.pro rank
Remifemin industry classification
Industry- Product category
- Women's Health Pharmaceuticals
- NAICS
- Toilet Preparation Manufacturing (32562)
- SIC
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
- akta.pro primary industry
- Sleep, Stress & Mood Support (HLAIADAG)
Keywords
Where Remifemin is headquartered
LocationHeadquarters
- HQ city
- Salzgitter
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Remifemin business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Pharmaceutical Product Sales: Remifemin products (Remifemin plus Johanniskraut, Remifemin, Remifemin mono, Remifemin FeuchtCreme) are sold exclusively through pharmacies as over-the-counter (OTC) pharmaceutical products. Products are purchased as one-time transactions but with repeat purchase potential as they are used for ongoing treatment of menopause symptoms.
- Online Pharmacy Sales: Products available through online pharmacy platforms and marketplaces including Amazon, DocMorris, ShopApotheke, Medikamente-per-Klick, ApoDiscounter, and others. These channels provide additional revenue stream through e-commerce distribution.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Remifemin plus Johanniskraut - 60 film-coated tablets |
| Unit Pricing | Pay-as-you-go | Remifemin plus Johanniskraut - 100 film-coated tablets |
| Unit Pricing | Pay-as-you-go | Remifemin plus Johanniskraut - 180 film-coated tablets |
| Unit Pricing | Pay-as-you-go | Remifemin - 60 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin - 100 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin - 200 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin mono - 30 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin mono - 60 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin mono - 90 tablets |
| Unit Pricing | Pay-as-you-go | Remifemin FeuchtCreme - 50g |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Remifemin product offering
Product offeringCore offering
Remifemin is a product brand of Schaper & Brümmer GmbH & Co. KG that manufactures and sells a family of hormone-free herbal medicines containing the proprietary iCR-Special Extract from Black Cohosh (Cimicifuga racemosa) for the treatment of menopausal symptoms including hot flashes, night sweats, sleep disturbances, mood swings, and vaginal dryness. The portfolio includes oral tablets (Remifemin plus Johanniskraut, Remifemin, Remifemin mono) and a vaginal moisturizing cream, distributed exclusively through pharmacies.
Product overview
Remifemin is a hormone-free herbal medicine product family manufactured by Schaper & Brümmer GmbH & Co. KG in Germany for treating menopause symptoms. The core product line consists of three oral medications containing iCR-special extract from black cohosh (Traubensilberkerze): Remifemin plus Johanniskraut for stronger psychological and physical symptoms, Remifemin for lighter symptoms, and Remifemin mono for once-daily dosing convenience. These are complemented by Remifemin FeuchtCreme, a hormone-free moisturizing cream for vaginal dryness, and the Remifemin Wechseljahre App for digital menopause tracking and support. All products are pharmacy-only medications (apothekenpflichtig) except the FeuchtCreme which is a medical device.
Differentiator
Problem solved
Functional benefit
Brands
- Remifemin plus Johanniskraut: Hormone-free herbal medicine for menopause symptoms including hot flashes, excessive sweating, nervousness, irritability, and depressive moods.
- Remifemin
- Remifemin mono
- Remifemin FeuchtCreme
- Remifemin Wechseljahre App
Products and services
- Remifemin plus Johanniskraut
- Remifemin Hormone-free herbal medicine with standard dosage of iCR-special extract from Black Cohosh (Traubensilberkerze) for treating lighter menopause symptoms such as hot flashes, sweating, and sleep disturbances. Taken twice daily. Available in 60, 100, and 200 tablet pack sizes. Sold exclusively through pharmacies.
- Remifemin mono Single-dose daily formulation of Black Cohosh iCR-special extract designed for once-daily intake convenience to treat milder menopause symptoms. Contains the same active ingredient as Remifemin. Available in 30, 60, and 90 tablet pack sizes. Sold exclusively through pharmacies.
- Remifemin FeuchtCreme Medical device cream containing hamamelis water (witch hazel) for treating vaginal dryness during menopause. Contains lactic acid (pH 4.2-4.5) and is free from hormones, fragrances, dyes, silicones, and parabens. Available in 50g size. Sold exclusively through pharmacies.
- Remifemin Wechseljahre App Free mobile application companion for menopause management providing daily exercise reminders, expert knowledge, symptom tracking, menopause self-tests, and product scanning for feature unlocking. All app functions are free for Remifemin product customers. Available for iOS and Android.
Quantifiable outcome
- Efficacy and tolerability demonstrated in 30+ studies with 13,000+ patients
- +1 more outcomes
Companies that use Remifemin
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Remifemin technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
Remifemin partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Remifemin competitors and assessment
Company assessmentDirect peers
- Schwabe Group: Major German herbal pharmaceutical manufacturer with pharmacy-only distribution and extensive clinical research on botanical extracts. Comparable business model, regulatory positioning, and evidence-based herbal product strategy.
- Bionorica: German phytopharmaceutical company producing clinically validated herbal medicines sold primarily through pharmacies. Directly comparable as a European-based herbal OTC player with strong clinical evidence and pharmacy distribution.
- Estroven: US-based hormone-free menopause symptom supplement brand with multi-SKU portfolio targeting hot flashes, sleep, and mood. Directly comparable OTC consumer product targeting the same menopausal symptom categories.
- Biologische Heilmittel Heel: German pharmaceutical company specializing in plant-based and homeopathic medicines distributed through pharmacies. Comparable as a herbal/natural medicine manufacturer with pharmacy channel focus and women's health products.
- Amberen: Hormone-free menopause relief supplement brand sold OTC. Comparable as a non-prescription menopause symptom solution targeting similar customer demographics.
Broad incumbents
- Organon: Global women's health pharmaceutical company with established menopause hormone therapy franchises. Comparable end market but broader prescription-led portfolio versus Remifemin's OTC herbal approach.
- Theramex: Global specialty pharmaceutical company focused exclusively on women's health, including menopause hormone therapy and related products. Comparable women's health focus with broader prescription portfolio.
Emerging players
- Bonafide Health: DTC-focused women's health brand with clinically studied, non-hormonal menopause and perimenopause products. Comparable target customer and hormone-free positioning, but with a direct-to-consumer vs. pharmacy distribution model.
- Gaia Herbs: US herbal supplement brand offering Black Cohosh and other women's health botanicals. Comparable use of Cimicifuga-based ingredients and women's wellness category, though more supplement-positioned and DTC.
- EVEN: Direct-to-consumer women's wellness company offering supplements for perimenopause and menopause symptom relief. Comparable customer base and product category, with a modern DTC and digital engagement approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Remifemin social profiles
Digital presenceRemifemin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Remifemin leadership team
Management profileNumber of profiles
Remifemin funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Remifemin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Remifemin
What does Remifemin do?
Remifemin is a product brand of Schaper & Brümmer GmbH & Co. KG that manufactures and sells a family of hormone-free herbal medicines containing the proprietary iCR-Special Extract from Black Cohosh (Cimicifuga racemosa) for the treatment of menopausal symptoms including hot flashes, night sweats, sleep disturbances, mood swings, and vaginal dryness. The portfolio includes oral tablets (Remifemin plus Johanniskraut, Remifemin, Remifemin mono) and a vaginal moisturizing cream, distributed exclusively through pharmacies.
Is Remifemin a public or private company?
Remifemin is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Remifemin founded?
Remifemin was founded in -1.
Where is Remifemin based?
Remifemin is headquartered in Salzgitter, Germany, in the Europe region.
How does Remifemin make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are online Pharmacy Sales.
Who are Remifemin's main competitors?
Direct peers on record are Schwabe Group, Bionorica, Estroven, Biologische Heilmittel Heel and Amberen. Broad incumbents are Organon and Theramex. Emerging players are Bonafide Health, Gaia Herbs and EVEN.
Does Remifemin have an API?
No public API is recorded for Remifemin.
What industry is Remifemin in?
Remifemin's product category is Women's Health Pharmaceuticals. Its primary akta.pro industry code is HLAIADAG, Sleep, Stress & Mood Support. Its NAICS code is 32562 and its SIC code is 2840.